TFA
KMTS

Transamerica Financial Advisors’s Kestra Medical Technologies KMTS Stock Holding History

Transamerica Financial Advisors’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-27
Closed -$642 – 1934
2025
Q3 		$642 Buy
+27
New +$483 ﹤0.01% 1252

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Transamerica Financial Advisors's KMTS Position: Q4 2025 in Review

Transamerica Financial Advisors sold out of Kestra Medical Technologies (KMTS) in Q4 2025, closing a stake of 27 shares — an estimated $642 sold.

Transamerica Financial Advisors first reported a position in KMTS in Q3 2025 and held it in 1 quarter. The position peaked at $642 in Q3 2025. 107 funds tracked by Wall St. Rank hold KMTS as of Q4 2025.

  • Transamerica Financial Advisors reported no remaining Kestra Medical Technologies position as of Q4 2025 after selling out during the quarter.
  • Transamerica Financial Advisors sold 27 Kestra Medical Technologies shares in Q4 2025, an estimated $642.
  • Transamerica Financial Advisors first reported a position in Kestra Medical Technologies in Q3 2025 and held it in 1 quarter.
  • Transamerica Financial Advisors's Kestra Medical Technologies position peaked at $642 in Q3 2025.
  • 107 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q4 2025.

Based on Transamerica Financial Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.